van der Waal I. Oral potentially malignant disorders: Is malignant transformation
predictable and preventable?. Med Oral Patol Oral Cir Bucal. 2014
July 1;19 (4):e386-90.
doi:10.4317/medoral.20205
http://dx.doi.org/doi:10.4317/medoral.20205
|
1. Kramer
IR, Lucas RB, Pindborg JJ, Sobin
LH. Definition
of leukoplakia and related lesions: an aid to
studies on oral precancer. Oral Surg
Oral Med Oral Pathol. 1978;46:518-39. |
|
|
|
|
|
2. Warnakulasuriya S, Johnson NW, van der
Waal I. Nomenclature and classification of potentially malignant disorders of
the oral mucosa. J Oral Pathol Med. 2007;36:575-80. |
|
|
|
|
|
3. Reichart PA, Philipsen HP. Oral
erythroplakia. A review. Oral Oncol.
2005;41:551-61. |
|
|
|
|
|
4. Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term
treatment outcome of oral premalignant lesions. Oral Oncol. 2006;42:461-74. |
|
|
|
|
|
5. Zhang
L, Williams M, Poh CF, Laronde
D, Epstein JB. Toluidine blue staining identifies
high-risk primary oral premalignant lesion with poor outcome. Cancer Res. 2005;65:8017-21. |
|
|
|
|
|
6. Nasser
W, Flechtenmacher Chr, Holzinger D, Hofele Chr, Bosch FX. Aberrant expression of p53, p16INK4a and
Ki-67 as basic biomarker for malignant progression of oral leukoplakias. J Oral Pathol
Med. 2011;40:629-35. |
|
|
|
|
|
7. Siebers TJH, Bergshoeff VE, Otte-Höller I, Kremer B, Speel
EJM, van der Laak JAWM,
et al. Oral Oncology. 2013;49:1121-1128. |
|
|
|
|
|
8. Graveland AP, Bremmer JF, de Maaker M, Brink A, Cobussen P, Zwart M, et al. Molecular screening of oral precancer. Oral Oncol. 2013;49:1129-35. |
|
|
|
|
|
9. Brouns EREA, Baart JA, Karagozoglu KH, Aartman IHA, Bloemena E, van der Waal I.
Treat-ment results of CO2 laser vaporisation
in a cohort of 35 patients with oral leukoplakia. Oral Dis. 2013;19:212-6. |
|
|
|
|
|
10. Kuribayashi Y, Tsushima F, Sato M, Morita K, Omura K. Recurrence patterns of oral leu-koplakia
after curtaive surgical resection: important
factors that predict the risk of recurrence and malignancy. J Oral Pathol. 2012;41:682-8. |
|
|
|
|
|
11. Arnaoutakis D, Bishop J, Westra
W, Califano JA. Recurrence patterns and management
of oral cavity premalignant lesions. Oral Oncol. 2013;49:814-7. |
|
|
|
|
|
12. Arduino PG, Surace A, Carbone
M, Elia A, Massolini G,
Gandolfo S, et al, Outcome of oral dysplasia: a retrospective hospital-based
study of 207 patients with a long follow-up. J Oral Pathol
Med. 2009;38:540-4. |
|
|
|
|
|
13. Brouns EREA, Baart JA, Karagozoglu KH, Aartman IHA, Bloemena E, van der Waal I. Malig-nant transformation of oral leukoplakia
in a well defined cohort of 144 patients. Oral Dis. 2014;20:e19-24. |
|
|
|
|
|
14. Einhorn J, Wersall J. Incidence
of oral carcinoma in patients with leukoplakia of
the oral mucosa. Cancer. 1967;20:2189-93. |
|
|
|
|
|
15. Lodi
G, Sardella A, Bez C, Demarosi F, Carrassi A.
Interventions for treating oral leukoplakia. Cochrane Database Syst
Rev. 2006:CD001829. |
|
|
|
|
|
16. Ribeiro AS, Salles PR, da Silva TA, Mesquita
RA. A review
of the nonsurgical treatment of oral leukoplakia. Int J Dent. 2010;2010:186018. |
|
|
|
|
|
17. Vladimirov BS, Schiödt M. The
effect of quitting smoking on the risk of unfavorable events after surgical
treatment of oral potentially malignant lesions. Int
J Oral Maxillofac Surg. 2009;38:1188-93. |
|
|
|
|
|
18. Krutchkoff DJ, Cutler L, Laskowski
S. Oral lichen planus: the evidence regarding
potential ma-lignant transformation. J Oral Pathol. 1978;7:1-7. |
|
|
|
|
|
19. Voûte ABE, de Jong WFB, Schulten EAJM, Snow GB, van der
Waal I. The possible premalig-nant character of
oral lichen planus; the Amsterdam experience. J
Oral Pathol Med. 1992;21:326-9. |
|
|
|
|
|
20.
Eisenberg E. Clinical controversies in oral and maxillofacial surgery. Part
one. Oral lichen planus: a benign lesion. J Oral Maxillofac Surg. 2000;58:1278-85. |
|
|
|
|
|
21.Van der Meij
EH, Mast H, van der Waal I. The possible
premalignant character of oral lichen planus and
oral lichenoid lesions: a prospective five-year
follow-up study of 192 patients. Oral Oncol. 2007;43:742-8. |
|
|
|
|
|
22. Accurso BT, Warner BM, Knobloch
ThJ, Weghorst CM, Shumway BS, Allan CM, et al. Allelic imbalance in oral
lichen planus ans
assessment of its classification as a premalignant condition. Oral Surg Oral med Oral Pathol Oral Radiol Endod 2011;112:359-66. |
|
|
|
|
|
23. Poomsawat S, Buajeeb W, Khovidhunkit SO, Punyasingh J. Overexpression of cdk4 and p16 in oral lichen planus supports the concept of premalignancy.
J Oral Pathol Med. 2011;40:294-9. |
|
|
|
|
|
24. Bombeccari GP, Guzzi G, Tettamanti M, Gianni AD, Baj A,
Pallotti F, et al. Oral lichen planus
and malignant transformation: a longitudinal cohort study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112:328-34. |
|
|
|
|
|
25. Rad M, Hashemipoor MA, Mojtahedi A, Zarei MZ, Chamani G, Kakoei S, et al.
Correlation between clinical and histopathologic
diagnoses of oral lichen planus based on modified
WHO diag-nostic criteria. Oral Surg
Oral Med Oral Pathol Oral Radiol
Endod. 2009;107:796-800. |
|
|
|
|
|
26. Krutchkoff DJ, Eisenberg E. Lichenoid
dysplasia: a distinct histopathologic entity. Oral Surg Oral Med Oral Pathol. 1985;60:308-15. |
|
|
|
|
|
27. Mattila R, Alanen K, Syrjänen S. Desmocollin
expression in oral atrophic lichen planus corre-lates with clinical behavior and DNA content. J Cutan Pathol. 2008;35:832-8. |
|
|
|
|
|
28. Chen
Y, Zhang W, Geng N, Tian
K, Jack Windsor L. MMPs, TIMP-2, and TGF-beta 1 in the cancerization
of oral lichen planus. Head Neck. 2008;30:1237-45. |
|
|
|
|
|
29.
Gonzales-Moles MA, Scully C, Ruiz-Avila L. Molecular findings in oral
premalignant fields; update on their diagnostic and clinical implications. Oral Dis. 2012;18:40-7. |
|
|
|
|
|
30. Mattsson U, Jontell M, Holmstrup P. Oral lichen planus
and malignant transformation: Is a recall of patients justified?. Crit Rev Oral Biol Med. 2002;13:390-6. |
|
|
|
|
|
31. Mignona MD, Fedele S, Lo Russio L. Dysplasia/neoplasia
surveillance in oral lichen planus patients: a
description of clinical criteria adopted at a single centre and their impact
on prognosis. Oral Oncol.
2006;42:819-24. |
|